Skip to main content
SpringerLink
Log in

Obsessive-Compulsive Disorder

  • Chapter
  • First Online:
Psychiatric Neurotherapeutics

Part of the book series: Current Clinical Psychiatry ((CCPSY))

Abstract

Obsessive-compulsive disorder (OCD) is a very common disease that affects approximately 2–3 % of the general population across the lifespan [APA (Diagnostic and statistical manual of mental disorders. APA, 1994)]. OCD has been listed as one of the ten most disabling illnesses by the World Health Organization [Murray and Lopez (Science 274(5288): 740–743, 1996)], while the National Comorbidity Survey Replication identified it as the anxiety disorder with the highest proportion of serious cases (50.6 %) [Kessler et al. (Arch Gen Psychiatry 62(6): 617–627, 2005)]. Many individuals with OCD receive markedly delayed diagnosis and treatment for this illness [Jenike (N Engl J Med 350(3): 259–265, 2004)]. Although it has a waxing and waning course, it frequently increases in severity due to ritual reinforcement when left untreated. Hence, improved understanding of OCD by clinicians is imperative to reduce the gap between symptom onset and eventual diagnosis and to promote early implementation of strategies for long-term symptomatic relief. This chapter will provide a general description of clinical features, assessment strategies, and treatment of OCD.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Jenike MA. Clinical practice. Obsessive-compulsive disorder. N Engl J Med. 2004;350(3):259–65.

    Google Scholar 

  2. APA. Diagnostic statistical manual of mental disorders. 5th ed. Washington, DC: APA; 1994.

    Google Scholar 

  3. Murray CJ, Lopez AD. Evidence-based health policy—lessons from the global burden of disease study. Science. 1996;274(5288):740–3.

    Article  CAS  PubMed  Google Scholar 

  4. Muris P, Merckelbach H, Clavan M. Abnormal and normal compulsions. Behav Res Ther. 1997;35(3):249–52.

    Article  CAS  PubMed  Google Scholar 

  5. Salkovskis PM, Harrison J. Abnormal and normal obsessions—a replication. Behav Res Ther. 1984;22(5):549–52.

    Article  CAS  PubMed  Google Scholar 

  6. Stein MB, et al. Obsessive-compulsive disorder in the community: an epidemiologic survey with clinical reappraisal. Am J Psychiatry. 1997;154(8):1120–6.

    Article  CAS  PubMed  Google Scholar 

  7. Crino R, Slade T, Andrews G. The changing prevalence and severity of obsessive-compulsive disorder criteria from DSM-III to DSM-IV. Am J Psychiatry. 2005;162(5):876–82.

    Article  PubMed  Google Scholar 

  8. Kessler RC, et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593–602.

    Article  PubMed  Google Scholar 

  9. Karno M, et al. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry. 1988;45(12):1094–9.

    Article  CAS  PubMed  Google Scholar 

  10. Kessler RC, et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):617–27.

    Google Scholar 

  11. Weissman MM, et al. The cross national epidemiology of obsessive compulsive disorder. The Cross National Collaborative Group. J Clin Psychiatry. 1994;55(Suppl):5–10.

    PubMed  Google Scholar 

  12. Burke KC, et al. Age at onset of selected mental disorders in five community populations. Arch Gen Psychiatry. 1990;47(6):511–8.

    Article  CAS  PubMed  Google Scholar 

  13. Maj M, et al. Obsessive-compulsive disorder. 2nd ed. Chichester: Wiley; 2002.

    Book  Google Scholar 

  14. Nestadt G, et al. Incidence of obsessive-compulsive disorder in adults. J Nerv Ment Dis. 1998;186(7):401–6.

    Article  CAS  PubMed  Google Scholar 

  15. Weiss AP, Jenike MA. Late-onset obsessive-compulsive disorder: a case series. J Neuropsychiatry Clin Neurosci. 2000;12(2):265–8.

    Article  CAS  PubMed  Google Scholar 

  16. Rosario-Campos MC, et al. Adults with early-onset obsessive-compulsive disorder. Am J Psychiatry. 2001;158(11):1899–903.

    Article  CAS  PubMed  Google Scholar 

  17. Geller DA, et al. Obsessive-compulsive disorder in children and adolescents: a review. Harv Rev Psychiatry. 1998;5(5):260–73.

    Article  CAS  PubMed  Google Scholar 

  18. Fontenelle LF, et al. Early- and late-onset obsessive-compulsive disorder in adult patients: an exploratory clinical and therapeutic study. J Psychiatr Res. 2003;37(2):127–33.

    Article  PubMed  Google Scholar 

  19. Stewart SE, et al. Long-term outcome of pediatric obsessive-compulsive disorder: a meta-analysis and qualitative review of the literature. Acta Psychiatr Scand. 2004;110(1):4–13.

    Article  CAS  PubMed  Google Scholar 

  20. Eichstedt JA, Arnold SL. Childhood-onset obsessive-compulsive disorder: a tic-related subtype of OCD? Clin Psychol Rev. 2001;21(1):137–57.

    Article  CAS  PubMed  Google Scholar 

  21. Geller DA, et al. Developmental aspects of obsessive compulsive disorder: findings in children, adolescents, and adults. J Nerv Ment Dis. 2001;189(7):471–7.

    Article  CAS  PubMed  Google Scholar 

  22. Tukel R, et al. Influence of age of onset on clinical features in obsessive-compulsive disorder. Depress Anxiety. 2005;21(3):112–7.

    Article  PubMed  Google Scholar 

  23. Flament MF, et al. Obsessive compulsive disorder in adolescence: an epidemiological study. J Am Acad Child Adolesc Psychiatry. 1988;27(6):764–71.

    Article  CAS  PubMed  Google Scholar 

  24. Heyman I, et al. Prevalence of obsessive-compulsive disorder in the British nationwide survey of child mental health. Br J Psychiatry. 2001;179:324–9.

    Article  CAS  PubMed  Google Scholar 

  25. Douglass HM, et al. Obsessive-compulsive disorder in a birth cohort of 18-year-olds: prevalence and predictors. J Am Acad Child Adolesc Psychiatry. 1995;34(11):1424–31.

    Article  CAS  PubMed  Google Scholar 

  26. Giulino L, et al. Is parental report of upper respiratory infection at the onset of obsessive-compulsive disorder suggestive of pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection? J Child Adolesc Psychopharmacol. 2002;12(2):157–64.

    Article  PubMed  Google Scholar 

  27. Snider LA, Swedo SE. Childhood-onset obsessive-compulsive disorder and tic disorders: case report and literature review. J Child Adolesc Psychopharmacol. 2003;13 Suppl 1:S81–8.

    Article  PubMed  Google Scholar 

  28. Murphy TK, et al. Detecting pediatric autoimmune neuropsychiatric disorders associated with streptococcus in children with obsessive-compulsive disorder and tics. Biol Psychiatry. 2004;55(1):61–8.

    Article  PubMed  Google Scholar 

  29. Pauls DL. Update on the genetics of Tourette syndrome. Adv Neurol. 2001;85:281–93.

    CAS  PubMed  Google Scholar 

  30. Pauls DL, Mundo E, Kennedy JL. The pathophysiology and genetics of obsessive-compulsive disorder. In: Fineberg F, Marazziti D, Stein D, editors. Obsessive compulsive disorder: a practical guide. London: Martin Dunitz Ltd; 2002. p. 61–75.

    Google Scholar 

  31. Pauls DL, et al. A family study of obsessive-compulsive disorder. Am J Psychiatry. 1995;152(1):76–84.

    Article  CAS  PubMed  Google Scholar 

  32. Nestadt G, et al. A family study of obsessive-compulsive disorder. Arch Gen Psychiatry. 2000;57(4):358–63.

    Article  CAS  PubMed  Google Scholar 

  33. Hettema JM, Neale MC, Kendler KS. A review and meta-analysis of the genetic epidemiology of anxiety disorders. Am J Psychiatr. 2001;158:1568–78.

    Article  CAS  PubMed  Google Scholar 

  34. Lenane MC, et al. Psychiatric disorders in first degree relatives of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry. 1990;29:407–12.

    Article  CAS  PubMed  Google Scholar 

  35. Riddle MA, et al. Obsessive compulsive disorder in children and adolescents: phenomenology and family history. J Am Acad Child Adolesc Psychiatry. 1990;29:766–72.

    Article  CAS  PubMed  Google Scholar 

  36. Bellodi L, et al. Psychiatric disorders in the families of patients with obsessive-compulsive disorder. Psychiatry Res. 1992;42:111–20.

    Article  CAS  PubMed  Google Scholar 

  37. Leonard H, et al. Tics and Tourette’s disorder: a 2- to 7-year follow-up of 54 obsessive-compulsive children. Am J Psychiatr. 1992;149:1244–51.

    Article  CAS  PubMed  Google Scholar 

  38. Reddy PS, et al. A family study of juvenile obsessive-compulsive disorder. Can J Psychiatr. 2001;46(4):346–51.

    CAS  Google Scholar 

  39. Chabane N, et al. Early-onset obsessive-compulsive disorder: a subgroup with a specific clinical and familial pattern? J Child Psychol Psychiatry. 2005;46(8):881–7.

    Article  PubMed  Google Scholar 

  40. Rosario-Campos MC, et al. A family study of early-onset obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet. 2005;136(1):92–7.

    Article  Google Scholar 

  41. van Grootheest DS, et al. Twin studies on obsessive-compulsive disorder: a review. Twin Res Hum Genet. 2005;8(5):450–8.

    Article  PubMed  Google Scholar 

  42. Cavallini MC, et al. Complex segregation analysis for obsessive compulsive disorder and related disorders. Am J Med Genet. 1999;88(1):38–43.

    Article  CAS  PubMed  Google Scholar 

  43. Nestadt G, et al. Complex segregation analysis provides compelling evidence for a major gene underlying obsessive-compulsive disorder and for heterogeneity by sex. Am J Hum Genet. 2000;67:1611–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Hanna GL, et al. Complex segregation analysis of obsessive-compulsive disorder in families with pediatric probands. Hum Hered. 2005;60(1):1–9.

    Article  PubMed  Google Scholar 

  45. Nicolini H, et al. Segregation analysis of obsessive compulsive disorders. Preliminary results. Ursus Medicus. 1991;1:25–8.

    Google Scholar 

  46. Hanna GL, et al. Genome-wide linkage analysis of families with obsessive-compulsive disorder ascertained through pediatric probands. Am J Med Genet Neuropsychiatr Genet. 2002;114:541–52.

    Article  Google Scholar 

  47. Zhang H, et al. Genomewide scan of hoarding in sib pairs in which both sibs have Gilles de la Tourette syndrome. Am J Hum Genet. 2002;70(4):896–904.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Shugart YY, et al. Genomewide linkage scan for obsessive-compulsive disorder: evidence for susceptibility loci on chromosomes 3q, 7p, 1q, 15q, and 6q. Mol Psychiatry. 2006;11(8):763–70.

    Article  CAS  PubMed  Google Scholar 

  49. Hanna GL, et al. Serotonin transporter and seasonal variation in blood serotonin in families with obsessive-compulsive disorder. Neuropsychopharmacology. 1998;18:102–11.

    Article  CAS  PubMed  Google Scholar 

  50. Mundo E, et al. 5HT1Dbeta Receptor gene implicated in the pathogenesis of obsessive-compulsive disorder: further evidence from a family-based association study. Mol Psychiatry. 2002;7(7):805–9.

    Article  CAS  PubMed  Google Scholar 

  51. Hu XZ, et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet. 2006;78(5):815–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  52. Enoch MA, et al. Sexually dimorphic relationship of a 5-HT2A promoter polymorphism with obsessive-compulsive disorder. Biol Psychiatry. 2001;49(4):385–8.

    Article  CAS  PubMed  Google Scholar 

  53. Kim SJ, et al. Mutation screening of human 5-HT2B receptor gene in early-onset obsessive-compulsive disorder. Mol Cell Probes. 2000;14:47–52.

    Article  PubMed  CAS  Google Scholar 

  54. Cavallini MC, et al. 5HT2C CYS23/SER23 polymorphism is not associated with obsessive-compulsive disorder. Psychiatry Res. 1998;77:97–104.

    Article  CAS  PubMed  Google Scholar 

  55. Walitza S, et al. Transmission disequilibrium studies in children and adolescents with obsessive-compulsive disorders pertaining to polymorphisms of genes of the serotonergic pathway. J Neural Transm. 2004;111(7):817–25.

    Article  CAS  PubMed  Google Scholar 

  56. Billett EA, et al. Investigation of dopamine system genes in obsessive-compulsive disorder. Psychiatr Genet. 1998;8:163–9.

    Article  CAS  PubMed  Google Scholar 

  57. Rowe DC, et al. The relation of the dopamine transporter gene (DAT1) to symptoms of internalizing disorders in children. Behav Genet. 1998;28(3):215–25.

    Article  CAS  PubMed  Google Scholar 

  58. Cruz C, et al. Increased prevalence of the seven-repeat variant of the dopamine D4 receptor gene in patients with obsessive-compulsive disorder with tics. Neurosci Lett. 1997;231(1):1–4.

    Article  CAS  PubMed  Google Scholar 

  59. Alsobrook 2nd JP, et al. Association between the COMT locus and obsessive-compulsive disorder in females but not males. Am J Med Genet. 2002;114(1):116–20.

    Article  PubMed  Google Scholar 

  60. Camarena B, et al. Additional evidence that genetic variation of MAO-A gene supports a gender subtype in obsessive-compulsive disorder. Am J Med Genet Neuropsychiatr Genet. 2001;105:279–82.

    Article  CAS  Google Scholar 

  61. Karayiorgou M, et al. Family-based association studies support a sexually-dimorphic effect of COMT and MAOA on genetic susceptibility to obsessive-compulsive disorder. Biol Psychiatry. 1999;45:1178–89.

    Article  CAS  PubMed  Google Scholar 

  62. Delorme R, et al. Frequency and transmission of glutamate receptors GRIK2 and GRIK3 polymorphisms in patients with obsessive compulsive disorder. Neuroreport. 2004;15(4):699–702.

    Article  CAS  PubMed  Google Scholar 

  63. Stewart SE, et al. Family-based association between obsessive-compulsive disorder and glutamate receptor candidate genes. New York, NY: World Congress of Psychiatric Genetics; 2007.

    Google Scholar 

  64. Arnold PD, et al. Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study. Psychopharmacology (Berl). 2004;174(4):530–8.

    Article  CAS  Google Scholar 

  65. Arnold PD, et al. Glutamate transporter gene SLC1A1 associated with obsessive-compulsive disorder. Arch Gen Psychiatry. 2006;63(7):769–76.

    Article  CAS  PubMed  Google Scholar 

  66. Dickel DE, et al. Association testing of the positional and functional candidate gene SLC1A1/EAAC1 in early-onset obsessive-compulsive disorder. Arch Gen Psychiatry. 2006;63(7):778–85.

    Article  CAS  PubMed  Google Scholar 

  67. Stewart SE, et al. A genetic family-based association study of OLIG2 in obsessive-compulsive disorder. Arch Gen Psychiatry. 2007;64(2):209–14.

    Article  CAS  PubMed  Google Scholar 

  68. Welch JM, et al. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature. 2007;448(7156):894–900.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Zai G, et al. Myelin oligodendrocyte glycoprotein (MOG) gene is associated with obsessive-compulsive disorder. Am J Med Genet B Neuropsychiatr Genet. 2004;129(1):64–8.

    Article  Google Scholar 

  70. Stewart SE, et al. Genome-wide association study of obsessive-compulsive disorder. Mol Psychiatry. 2013;18(7):788–98.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Foa EB, et al. The obsessive-compulsive inventory: development and validation of a short version. Psychol Assess. 2002;14(4):485–96.

    Article  PubMed  Google Scholar 

  72. Yovel I, et al. The obsessive-compulsive symptoms rating inventory: development and psychometric analysis. In: 37th annual convention of the association for the advancement of behavior therapy, Boston; 2003.

    Google Scholar 

  73. Stewart SE, Hu YP, Hezel DM, Proujansky R, Lamstein A, Walsh C, Ben-Joseph EP, Gironda C, Jenike M, Geller DA, Pauls DL. Development and Psychometric Properties of the OCD Family Functioning (OFF) Scale. J Fam Psychol. 2011;25(3):434–43.

    Google Scholar 

  74. Stewart SE, et al. Predictors of family accommodation in obsessive-compulsive disorder. Ann Clin Psychiatry. 2008;20(2):65–70.

    Article  PubMed  Google Scholar 

  75. Rubenstein CS, et al. A preliminary investigation of the lifetime prevalence of anorexia and bulimia nervosa in patients with obsessive compulsive disorder. J Clin Psychiatry. 1992;53(9):309–14.

    CAS  PubMed  Google Scholar 

  76. Keuthen NJ, et al. The Massachusetts General Hospital (MGH) hairpulling scale: 1. development and factor analyses. Psychother Psychosom. 1995;64(3–4):141–5.

    Article  CAS  PubMed  Google Scholar 

  77. Phillips KA. Instruments for assessing BDD: the BDDQ: a self-reporting screening instrument for BDD. The broken mirror. New York: Oxford University Press; 1996. p. 321–33.

    Google Scholar 

  78. Perugi G, et al. Obsessive-compulsive-bipolar comorbidity: a systematic exploration of clinical features and treatment outcome. J Clin Psychiatry. 2002;63(12):1129–34.

    Article  PubMed  Google Scholar 

  79. Diniz JB, et al. Impact of age at onset and duration of illness on the expression of comorbidities in obsessive-compulsive disorder. J Clin Psychiatry. 2004;65(1):22–7.

    Article  PubMed  Google Scholar 

  80. LaSalle VH, et al. Diagnostic interview assessed neuropsychiatric disorder comorbidity in 334 individuals with obsessive-compulsive disorder. Depress Anxiety. 2004;19(3):163–73.

    Article  PubMed  Google Scholar 

  81. Mell LK, Davis RL, Owens D. Association between streptococcal infection and obsessive-compulsive disorder, Tourette’s syndrome, and tic disorder. Pediatrics. 2005;116(1):56–60.

    Article  PubMed  Google Scholar 

  82. Dale RC, et al. Incidence of anti-brain antibodies in children with obsessive-compulsive disorder. Br J Psychiatry. 2005;187:314–9.

    Article  PubMed  Google Scholar 

  83. Eisen JL, et al. The brown assessment of beliefs scale: reliability and validity. Am J Psychiatry. 1998;155(1):102–8.

    Article  CAS  PubMed  Google Scholar 

  84. Katz RJ, DeVeaugh-Geiss J, Landau P. Clomipramine in obsessive-compulsive disorder. Biol Psychiatry. 1990;28(5):401–14.

    Article  CAS  PubMed  Google Scholar 

  85. The Clomipramine Collaborative Study Group. Clomipramine in the treatment of patients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1991;48(8):730–8.

    Article  Google Scholar 

  86. Mundo E, et al. Fluvoxamine in obsessive-compulsive disorder: similar efficacy but superior tolerability in comparison with clomipramine. Hum Psychopharmacol. 2001;16(6):461–8.

    Article  CAS  PubMed  Google Scholar 

  87. Foa EB, et al. Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry. 2005;162(1):151–61.

    Article  PubMed  Google Scholar 

  88. Montgomery SA, et al. A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder. The Lilly European OCD Study Group. Eur Neuropsychopharmacol. 1993;3(2):143–52.

    Article  CAS  PubMed  Google Scholar 

  89. Tollefson GD, et al. A multicenter investigation of fixed-dose fluoxetine in the treatment of obsessive-compulsive disorder. Arch Gen Psychiatry. 1994;51(7):559–67.

    Article  CAS  PubMed  Google Scholar 

  90. Greist JH, et al. A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder. Int Clin Psychopharmacol. 1995;10(2):57–65.

    Article  CAS  PubMed  Google Scholar 

  91. Greist J, et al. Double-blind parallel comparison of three dosages of sertraline and placebo in outpatients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1995;52(4):289–95.

    Article  CAS  PubMed  Google Scholar 

  92. Goodman WK, et al. Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial. Int Clin Psychopharmacol. 1996;11(1):21–9.

    Article  CAS  PubMed  Google Scholar 

  93. Zohar J, Judge R. Paroxetine versus clomipramine in the treatment of obsessive-compulsive disorder. OCD Paroxetine Study Investigators. Br J Psychiatry. 1996;169(4):468–74.

    Article  CAS  PubMed  Google Scholar 

  94. Kronig MH, et al. Placebo-controlled, multicenter study of sertraline treatment for obsessive-compulsive disorder. J Clin Psychopharmacol. 1999;19(2):172–6.

    Article  CAS  PubMed  Google Scholar 

  95. Koran LM, et al. Efficacy of sertraline in the long-term treatment of obsessive-compulsive disorder. Am J Psychiatry. 2002;159(1):88–95.

    Article  PubMed  Google Scholar 

  96. Denys D, et al. A double blind comparison of venlafaxine and paroxetine in obsessive-compulsive disorder. J Clin Psychopharmacol. 2003;23(6):568–75.

    Article  CAS  PubMed  Google Scholar 

  97. Hollander E, et al. A double-blind, placebo-controlled study of the efficacy and safety of controlled-release fluvoxamine in patients with obsessive-compulsive disorder. J Clin Psychiatry. 2003;64(6):640–7.

    Article  CAS  PubMed  Google Scholar 

  98. Hollander E, et al. Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine. J Clin Psychiatry. 2003;64(9):1113–21.

    Article  CAS  PubMed  Google Scholar 

  99. Kamijima K, et al. Paroxetine in the treatment of obsessive-compulsive disorder: randomized, double-blind, placebo-controlled study in Japanese patients. Psychiatry Clin Neurosci. 2004;58(4):427–33.

    Article  CAS  PubMed  Google Scholar 

  100. Sousa MB, et al. A randomized clinical trial of cognitive-behavioral group therapy and sertraline in the treatment of obsessive-compulsive disorder. J Clin Psychiatry. 2006;67(7):1133–9.

    Article  PubMed  Google Scholar 

  101. Stein DJ, et al. Escitalopram in obsessive-compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study. Curr Med Res Opin. 2007;23(4):701–11.

    Article  CAS  PubMed  Google Scholar 

  102. Fama JM, Wilhelm S. Formal cognitive therapy. A new treatment for obsessive-compulsive disorder. In: Abramowitz S, Houts A, editors. Handbook on controversial issues in obsessive-compulsive disorder. New York: Kluwer Academic Press; 2005. p. 263–81.

    Chapter  Google Scholar 

  103. Abramowitz JS. Effectiveness of psychological and pharmacological treatments for obsessive-compulsive disorder: a quantitative review. J Consult Clin Psychol. 1997;65(1):44–52.

    Article  CAS  PubMed  Google Scholar 

  104. Wilhelm S, et al. Effectiveness of cognitive therapy for obsessive-compulsive disorder: an open trial. J Cogn Psychother. 2005;19(2):173–9.

    Article  Google Scholar 

  105. Soomro GM, et al. Selective serotonin re-uptake inhibitors (SSRIs) versus placebo for obsessive compulsive disorder (OCD). Cochrane Database Syst Rev. 2008;1, CD001765.

    PubMed  Google Scholar 

  106. Jenike MA, Baer L, Minichiello WE. Obsessive-compulsive disorders: practical management. 3rd ed. St. Louis: Mosby; 1998.

    Google Scholar 

  107. Pigott TA, Seay SM. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. J Clin Psychiatry. 1999;60(2):101–6.

    Article  CAS  PubMed  Google Scholar 

  108. McDougle CJ, et al. Haloperidol addition in fluvoxamine-refractory obsessive compulsive disorder: a double blind placebo-controlled study in patients with and without tics. Arch Gen Psychiatry. 1994;51:302–8.

    Article  CAS  PubMed  Google Scholar 

  109. Pallanti S, Quercioli L, Bruscoli M. Response acceleration with mirtazapine augmentation of citalopram in obsessive-compulsive disorder patients without comorbid depression: a pilot study. J Clin Psychiatry. 2004;65(10):1394–9.

    Article  CAS  PubMed  Google Scholar 

  110. McDougle CJ, et al. Limited therapeutic effect of addition of buspirone in fluvoxamine-refractory obsessive-compulsive disorder. Am J Psychiatry. 1993;150(4):647–9.

    Article  CAS  PubMed  Google Scholar 

  111. McDougle CJ, et al. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Arch Gen Psychiatry. 2000;57(8):794–801.

    Article  CAS  PubMed  Google Scholar 

  112. Denys D, et al. A double-blind, randomized, placebo-controlled trial of quetiapine addition in patients with obsessive-compulsive disorder refractory to serotonin reuptake inhibitors. J Clin Psychiatry. 2004;65(8):1040–8.

    Article  CAS  PubMed  Google Scholar 

  113. Denys D, et al. A double-blind switch study of paroxetine and venlafaxine in obsessive-compulsive disorder. J Clin Psychiatry. 2004;65(1):37–43.

    Article  CAS  PubMed  Google Scholar 

  114. Crockett BA, Churchill E, Davidson JR. A double-blind combination study of clonazepam with sertraline in obsessive-compulsive disorder. Ann Clin Psychiatry. 2004;16(3):127–32.

    Article  PubMed  Google Scholar 

  115. Shapira NA, et al. A double-blind, placebo-controlled trial of olanzapine addition in fluoxetine-refractory obsessive-compulsive disorder. Biol Psychiatry. 2004;55(5):553–5.

    Article  CAS  PubMed  Google Scholar 

  116. Bogan AM, et al. Quetiapine augmentation in obsessive-compulsive disorder resistant to serotonin reuptake inhibitors: an open-label study. J Clin Psychiatry. 2005;66(1):73–9.

    Article  CAS  PubMed  Google Scholar 

  117. Erzegovesi S, et al. Low-dose risperidone augmentation of fluvoxamine treatment in obsessive-compulsive disorder: a double-blind, placebo-controlled study. Eur Neuropsychopharmacol. 2005;15(1):69–74.

    Article  CAS  PubMed  Google Scholar 

  118. Carey PD, et al. Quetiapine augmentation of SRIs in treatment refractory obsessive-compulsive disorder: a double-blind, randomised, placebo-controlled study [ISRCTN83050762]. BMC Psychiatry. 2005;5(1):5.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  119. Arias Horcajadas F, et al. Effectiveness and tolerability of addition of risperidone in obsessive-compulsive disorder with poor response to serotonin reuptake inhibitors. Actas Esp Psiquiatr. 2006;34(3):147–52.

    CAS  PubMed  Google Scholar 

  120. Hezel DM, Beattie K, Stewart SE. Memantine as an augmenting agent for severe pediatric OCD. Am J Psychiatry. 2009;166(2):237.

    Article  PubMed  Google Scholar 

  121. Pasquini M, Biondi M. Memantine augmentation for refractory obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(6):1173–5.

    Article  CAS  PubMed  Google Scholar 

  122. Poyurovsky M, et al. Memantine for treatment-resistant OCD. Am J Psychiatry. 2005;162(11):2191–2.

    Article  PubMed  Google Scholar 

  123. Kushner MG, et al. D-cycloserine augmented exposure therapy for obsessive-compulsive disorder. Biol Psychiatry. 2007;62(8):835–8.

    Article  CAS  PubMed  Google Scholar 

  124. Wilhelm S, et al. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder. Am J Psychiatry. 2008;165(3):335–41. quiz 409.

    Article  PubMed  Google Scholar 

  125. Stewart SE, et al. Outcome predictors for severe obsessive-compulsive patients in intensive residential treatment. J Psychiatr Res. 2006;40(6):511–9.

    Article  PubMed  Google Scholar 

  126. Stewart SE, et al. Effectiveness of intensive residential treatment (IRT) for severe, refractory obsessive-compulsive disorder. J Psychiatr Res. 2005;39(6):603–9.

    Article  PubMed  Google Scholar 

  127. Pato MT, et al. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder. Am J Psychiatry. 1988;145(12):1521–5.

    Article  CAS  PubMed  Google Scholar 

  128. Romano S, et al. Long-term treatment of obsessive-compulsive disorder after an acute response: a comparison of fluoxetine versus placebo. J Clin Psychopharmacol. 2001;21(1):46–52.

    Article  CAS  PubMed  Google Scholar 

  129. Skoog G, Skoog I. A 40-year follow-up of patients with obsessive-compulsive disorder (see comments). Arch Gen Psychiatry. 1999;56(2):121–7.

    Article  CAS  PubMed  Google Scholar 

  130. Rasmussen SA, Eisen JL. Clinical and epidemiologic findings of significance to neuropharmacologic trials in OCD. Psychopharmacol Bull. 1988;24(3):466–70.

    CAS  PubMed  Google Scholar 

  131. Angst J, et al. Obsessive-compulsive severity spectrum in the community: prevalence, comorbidity, and course. Eur Arch Psychiatry Clin Neurosci. 2004;254(3):156–64.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Psychiatry, B.C. Children’s Hospital, University of British Columbia, Vancouver, BC, Canada

    S. Evelyn Stewart M.D.

  2. Harvard Medical School, Boston, MA, USA

    S. Evelyn Stewart M.D.

Authors
  1. S. Evelyn Stewart M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S. Evelyn Stewart M.D. .

Editor information

Editors and Affiliations

  1. Medical School, Dept of Psychiatry, Massachusetts Gen Hosp, Harvard, Boston, Massachusetts, USA

    Joan A. Camprodon

  2. McLean Hospital, Belmont, Massachusetts, USA

    Scott L. Rauch

  3. Butler Hospital, Providence, Rhode Island, USA

    Benjamin D. Greenberg

  4. Harvard Medical School, Charleston, Massachusetts, USA

    Darin D. Dougherty

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this chapter

Cite this chapter

Stewart, S.E. (2016). Obsessive-Compulsive Disorder. In: Camprodon, J., Rauch, S., Greenberg, B., Dougherty, D. (eds) Psychiatric Neurotherapeutics. Current Clinical Psychiatry. Humana Press, New York, NY. https://doi.org/10.1007/978-1-59745-495-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-495-7_2

  • Published:

  • Publisher Name: Humana Press, New York, NY

  • Print ISBN: 978-1-934115-50-3

  • Online ISBN: 978-1-59745-495-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation